Results 171 to 180 of about 12,232 (185)

The effect of PCSK9 inhibitors on brain stroke prevention: A systematic review and meta-analysis

Nutrition, Metabolism and Cardiovascular Diseases, 2021
exaly  

In search of the pleiotropic effects of PCSK9 inhibitors

EuroIntervention, 2022
Räber, Lorenz, Ueki, Yasushi
openaire   +3 more sources

Pleiotropic Anti-atherosclerotic Effects of PCSK9 Inhibitors From Molecular Biology to Clinical Translation

Current Atherosclerosis Reports, 2018
Peter P Tóth, Shijia Zhao
exaly  

PCSK9 inhibitors and cardiovascular outcomes

Expert Opinion on Biological Therapy, 2020
Daniel Steffens, Peter Bramlage, Julian Friebel   +2 more
exaly  

PCSK9 Inhibitors: From Nature’s Lessons to Clinical Utility

Endocrine, Metabolic and Immune Disorders - Drug Targets, 2020
Frederick J Raäl, Robert Chilton, Naresh Ranjith   +2 more
exaly  

Oral PCSK9 inhibitor is effective and safe

Nature Reviews Cardiology, 2023
openaire   +2 more sources

PCSK9 inhibitors in clinical practice: Delivering on the promise?

Atherosclerosis, 2018
Robert M Stoekenbroek, Merel L Hartgers, Roger Rutte   +2 more
exaly  

The Pharmacologic Role and Clinical Utility of PCSK9 Inhibitors for the Treatment of Hypercholesterolemia

Journal of Cardiovascular Pharmacology and Therapeutics, 2018
C Michael White
exaly  

The Role of PCSK9 in the Pathogenesis of Non-alcoholic Fatty Liver Disease and the Effect of PCSK9 Inhibitors

Current Pharmaceutical Design, 2019
Eleni Theocharidou, Marianna Papademetriou, Andromachi Reklou   +2 more
exaly  

Cost-effectiveness of PCSK9 Inhibitor Therapy

JAMA, 2016
Vera, Mastey, Bryan M, Johnstone
openaire   +2 more sources